These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17523082)

  • 21. Prostate carcinoma and stem cells.
    Antón Aparicio LM; Cassinello Espinosa J; García Campelo R; Gómez Veiga F; Díaz Prado S; Aparicio Gallego G
    Clin Transl Oncol; 2007 Feb; 9(2):66-76. PubMed ID: 17329217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer and metastasis initiating stem cells.
    Kelly K; Yin JJ
    Cell Res; 2008 May; 18(5):528-37. PubMed ID: 18414448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
    Bisson I; Prowse DM
    Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cell cultures as models of prostate cancer development.
    Peehl DM
    Endocr Relat Cancer; 2005 Mar; 12(1):19-47. PubMed ID: 15788637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression.
    Knudsen BS; Miranti CK
    J Cell Biochem; 2006 Oct; 99(2):345-61. PubMed ID: 16676354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate Cancer Stem Cells: Research Advances.
    Jaworska D; Król W; Szliszka E
    Int J Mol Sci; 2015 Nov; 16(11):27433-49. PubMed ID: 26593898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unraveling the complex nature of prostate cancer stem cells.
    Foshay K; Miera A; Stuart A; Fingland N; Mobley S; Gallicano GI
    Cancer Biomark; 2007; 3(4-5):233-44. PubMed ID: 17917152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem cells in prostate cancer: treating the root of the problem.
    Taylor RA; Toivanen R; Risbridger GP
    Endocr Relat Cancer; 2010 Dec; 17(4):R273-85. PubMed ID: 20660571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis.
    van Leenders GJ; Schalken JA
    BJU Int; 2001 Sep; 88 Suppl 2():35-42; discussion 49-50. PubMed ID: 11589668
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts.
    Zhou Z; Flesken-Nikitin A; Nikitin AY
    Cancer Res; 2007 Jun; 67(12):5683-90. PubMed ID: 17553900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.
    Verhagen AP; Ramaekers FC; Aalders TW; Schaafsma HE; Debruyne FM; Schalken JA
    Cancer Res; 1992 Nov; 52(22):6182-7. PubMed ID: 1384957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
    Alberti C
    G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
    Bonkhoff H
    Prostate Suppl; 1998; 8():18-22. PubMed ID: 9690659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cells in prostate cancer.
    Mateo F; Fernandez PL; Thomson TM
    Arch Esp Urol; 2013 Jun; 66(5):475-86. PubMed ID: 23793765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An overview of concepts for cancer stem cells.
    Chen SY; Huang YC; Liu SP; Tsai FJ; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):113-20. PubMed ID: 20887682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.
    Sun Y; Wang BE; Leong KG; Yue P; Li L; Jhunjhunwala S; Chen D; Seo K; Modrusan Z; Gao WQ; Settleman J; Johnson L
    Cancer Res; 2012 Jan; 72(2):527-36. PubMed ID: 22108827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostate cancer and apoptosis].
    Mayora A; Arvelo F
    Invest Clin; 2011 Dec; 52(4):376-96. PubMed ID: 22523847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.
    Fujimura T; Takahashi S; Urano T; Takayama K; Sugihara T; Obinata D; Yamada Y; Kumagai J; Kume H; Ouchi Y; Inoue S; Homma Y
    Clin Cancer Res; 2014 Sep; 20(17):4625-35. PubMed ID: 24987058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies.
    Fioriti D; Mischitelli M; Di Monaco F; Di Silverio F; Petrangeli E; Russo G; Giordano A; Pietropaolo V
    J Cell Physiol; 2008 Sep; 216(3):571-5. PubMed ID: 18481259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.